Hamilton Thorne Ltd., a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, reported financial and operational results for the quarter and nine months ended September 30, 2022. Revenues were up 6% for the quarter and 14% for the nine months despite supply chain issues and significant foreign currency swings and organic growth was at 17% for the Quarter.

Read the full press release here: Hamilton Thorne Reports Financial and Operational Results for the Quarter and Nine Months Ended September 30, 2022